IL6 and COVID-19: Patients with COVID-19 and Self-RPD+ may experience sneezing, which leads to the dissemination of contaminated saliva and nasal secretions, promoting an increased SARS-CoV-2 viral load and the accumulation of soluble IL-6 (Figure 3).